Vaccines
Sanvita Biotechnologies Pvt. Ltd.
Vaccines
SanBru (Brucella S19 Vaccine) – Sanvita has a production capacity of 10 million doses per annum.
The vaccine conforms to IP Specifications. It is supplied with diluent.
Products in Pipeline
SanAphta (FMD Vaccine) – Sanvita is Commissioning FMD Production unit with a annual capacity of 200 million doses.
SanRab (Rabies Vaccine) – We will be coming out with 5 million doses of Rabies vaccine annually.
SanBlue (Bluetongue Vaccine) – We will be coming out with 15 million doses of Bluetongue vaccine annually.
SanBru-O (Brucella S19 Adult Vaccine) – This vaccine is sutaible for use in cattle beyound 4 monts age.
SanBru-REV1 (Brucella Melitensis) – This vaccine is meant for use in sheep & goat.
Bluetongue disease
Insect borne viral disease of domestic and wild ruminants, especially sheep
Morbidity: ~ 100%
Mortality: 0 to 50%
Quarantine and movement controls
Disinfection
Insect control
Vaccination
Brucellosis
| Bacterial species | Infected animals | Potential to infect humans | Health effects in animals |
| Brucella Melitensis | Sheep, Goat | +++ | Abortion
Delay in breeding Loss of lactation Low fertility among males |
| Brucella Abortus | Cattle | ++ | |
| Brucella suis | Pig | ++ | |
| Brucella canis | Dog | + | |
| Brucella ovis | Sheep | _ |
Brucellosis prevalence
Figure 1: The global map of brucellosis endemicity. Reproduced from the freely accessed article: Ariza 3, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 2007:4:e317 (doi:10.1371/journal.pmed.0040317). Reproduced from: Gutierrez Ruiz C, Miranda 33, Pappas G. A 26-year-old man with sternoclavicular arthritis. PLoS Med 2006:3:e293 (doi:10.1371/joumal.pmed.0030293). Derived from: Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91-99 [1]
Foot & Mouth Disease
Susceptible population in India (569 mn):Cattle, Buffaloes, Goats, Sheep, Pigs
More than 5000 outbreaks annually in the country
Highly Contagious
Vaccination is the agreed solution
Repeated Vaccination
Develops herd immunity
Gradually eradicates the virus
FMD vaccine demand – Worldwide
Susceptible population in SAARC countries: 260 mn
CIS countries – Around 70 million doses
SEA – Around 30 million doses
Middle East – Around 60 million doses
Africa – Around 30 million doses
FMD vaccine demand –India
FMD-CP : 600 mn doses per year
Other Schemes : 100 mn doses per year
Approximate Demand by 2019 : 800 mn doses per year
Vaccination will be done twice a year